Anuh Pharma Ltd - Stock Valuation and Financial Performance

BSE: 506260 | NSE: ANUHPHR | Pharmaceuticals & Drugs | Small Cap

Anuh Pharma Share Price

217.05 0.40 0.18%
as on 24-Dec'24 16:59

DeciZen - make an informed investing decision on Anuh Pharma

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Anuh Pharma stock performance -

mw4me loader
P/E Ratio (SA):
18.43
Market Cap:
1,087.7 Cr.
52-wk low:
145.7
52-wk high:
265

Is Anuh Pharma Ltd an attractive stock to invest in?

1. Is Anuh Pharma Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Anuh Pharma Ltd is a good quality company.

2. Is Anuh Pharma Ltd undervalued or overvalued?

The key valuation ratios of Anuh Pharma Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Anuh Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Anuh Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Anuh Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Anuh Pharma Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 35.1%34.9%21.6%16.3%20.6%10.9%19.8%19.3%21.1%29.7%-
Value Creation
Index
1.51.50.50.20.5-0.20.40.40.51.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 284326206238321307432487527647640
Sales YoY Gr.-15%-36.8%15.5%34.7%-4.3%40.7%12.7%8.4%22.7%-
Adj EPS 4.55.53.93.153.74.76.17.411.611.8
YoY Gr.-22.9%-29.4%-20.7%64.2%-27%26.9%31.3%20.1%57.2%-
BVPS (₹) 20.123.828.129.932.932.43842.748.158.160.5
Adj Net
Profit
22.327.519.415.425.318.523.430.736.95859
Cash Flow from Ops. 18.816.526.11.87.148.9-18.728.953.912.9-
Debt/CF from Ops. 00.101.30.60.9-0.70.100.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.6%15.1%14.4%22.7%
Adj EPS 11.2%18.1%35.3%57.2%
BVPS12.5%12.1%15.2%20.7%
Share Price 14.4% 28.1% 28.4% 45.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
23.92514.910.616.111.313.315.216.221.819.9
Op. Profit
Mgn %
11.912.3118.610.81010.510.110.211.811
Net Profit
Mgn %
7.98.49.46.57.965.46.3799.2
Debt to
Equity
000000.30.10000
Working Cap
Days
12711617615313916915316216615289
Cash Conv.
Cycle
2933586254473250485050

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 19.90%

Sales growth is growing at healthy rate in last 3 years 14.42%

Net Profit is growing at healthy rate in last 3 years 35.31%

Sales growth is not so good in last 4 quarters at 6.15%

Latest Financials - Anuh Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 11.8 -
TTM Sales (₹ Cr.) 640 -
BVPS (₹.) 60.5 -
Reserves (₹ Cr.) 278 -
P/BV 3.59 -
PE 18.43 -
From the Market
52 Week Low / High (₹) 145.65 / 265.00
All Time Low / High (₹) 0.03 / 265.00
Market Cap (₹ Cr.) 1,088
Equity (₹ Cr.) 25.1
Face Value (₹) 5
Industry PE 44.4

Management X-Ray of Anuh Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Anuh Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales284326206238321307432487527647
Operating Expenses 253289183220291284387439476571
Manufacturing Costs14181616202125273541
Material Costs220247149180241229328375399484
Employee Cost 6779101314151719
Other Costs 12171115192120212527
Operating Profit 31382318302345475276
Operating Profit Margin (%) 10.9%11.5%11.0%7.7%9.3%7.6%10.4%9.8%9.8%11.7%
Other Income 548754115612
Interest 1110112211
Depreciation 3222271512109
Exceptional Items 0000000000
Profit Before Tax 32382823321939394778
Tax 101287951091118
Profit After Tax 22262017231428313660
PAT Margin (%) 7.8%7.9%9.7%6.9%7.3%4.7%6.6%6.3%6.9%9.3%
Adjusted EPS (₹)4.45.24.03.34.72.95.76.17.212.0
Dividend Payout Ratio (%)27%24%31%42%29%48%26%29%28%21%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 101119141150165162191214241291
Share Capital 4131313131325252525
Reserves 97107128137152150166189216266
Minority Interest0000000000
Debt020244514302
Long Term Debt0000000000
Short Term Debt020244514302
Trade Payables4852425259105120122153141
Others Liabilities 1918541115891012
Total Liabilities 168191187208239326333347404445

Fixed Assets

Gross Block23331920279698100100104
Accumulated Depreciation13152451227384755
Net Fixed Assets9181717218471615349
CWIP 00063400000
Investments 43437066398031439197
Inventories16243032436181807375
Trade Receivables687557717581107136171190
Cash Equivalents 1413681132016710
Others Assets161878171821111024
Total Assets 168191187208239326333347404445

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 1916262749-19295413
PBT 32382823321939394778
Adjustment -1-1-5-2-28784-3
Changes in Working Capital -1-811-13-1327-55-916-44
Tax Paid -11-13-8-7-10-5-10-9-13-19
Cash Flow From Investing Activity -12-5-2023-7752-8-431
Capex -1-11-1-7-29-36-6-1-1-5
Net Investments -133-23629-4356-9-445
Others 2343332221
Cash Flow From Financing Activity -8-9-4-5-722-33-19-12-9
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 00000-1-2-100
Dividend Paid -8-11-2-8-8-170-8-9-10
Others 02-22239-32-11-32
Net Cash Flow -122-13-502-25
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)23.5523.4415.4311.3814.878.7516.1215.1115.922.56
ROCE (%)35.1334.9121.6116.3120.5610.8719.7519.3321.0529.66
Asset Turnover Ratio1.821.91.151.231.441.121.341.441.411.53
PAT to CFO Conversion(x)0.860.621.30.120.33.5-0.680.941.50.22
Working Capital Days
Receivable Days87761109682897890106101
Inventory Days22214546426059605342
Payable Days90741159684131125117125111

Anuh Pharma Ltd Stock News

Anuh Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Anuh Pharma on 24-Dec-2024 16:59 is ₹217.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Dec-2024 16:59 the market cap of Anuh Pharma stood at ₹1,087.7.
The latest P/E ratio of Anuh Pharma as of 24-Dec-2024 16:59 is 18.43.
The latest P/B ratio of Anuh Pharma as of 24-Dec-2024 16:59 is 3.59.
The 52-week high of Anuh Pharma is ₹265.0 and the 52-week low is ₹145.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Anuh Pharma is ₹639.9 ( Cr.) .

About Anuh Pharma Ltd

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506

Products

  • Macrolides
  • Higher Macrolides
  • Quinolones
  • Chloramphenicol
  • Anti TB Drug
  • Corticosteroids

Recognitions/Certifications

  • Anuh Pharma has received ‘Star Export House’ certification from the Ministry of Commerce and Industry.
  • The company received WHO-GMP certificate for carrying good manufacturing practices.
  • Anuh Pharma has received  ISO 9001:2000 certification
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.